Stocks to sell

Vinco Ventures (NASDAQ:BBIG) is a complicated company. Vinco is planning to merge with ZASH Global, it is acquiring digital advertising service AdRizer and it is spinning off its crypto business, Cryptyde. As a result of all these moves, BBIG stock has been quite volatile. Source: vincoventures.com Over time, however, it’s becoming clear that Vinco faces
0 Comments
Headquartered in Burlington, Mass., Desktop Metal (NYSE:DM) is an additive manufacturing company that’s mainly known for its 3D printing business. The terms “additive manufacturing” and “3D printing” might entice technology investors to consider a long position in DM stock, but be careful. Source: Pixel B / Shutterstock.com It’s entirely possible to believe in a business niche,
0 Comments
AMC Entertainment (NYSE:AMC) announces its Q4 2021 results today after the market closes. While they’re expected to be positive, that won’t save AMC stock. Source: Helen89 / Shutterstock.com In early February, I suggested that AMC’s best year from a financial perspective was 2018 when revenues were $5.46 billion with $265 million in operating profits.  Heading
0 Comments
In July of last year, Mad Money‘s Jim Cramer tried to warn prospective investors about Chinese ride-hailing giant DiDi Global (NYSE:DIDI). Referring to Chinese initial public offerings (IPOs) in general and DIDI stock in particular, Cramer cautioned, “you should steer clear of them at all cost.” Source: DANIEL CONSTANTE / Shutterstock.com In a similar vein, DoubleLine founder
0 Comments
Among the pandemic-era favorites, ContextLogic (NASDAQ:WISH) may be the one that’s seen the biggest reversal of fortune. Over the past year, WISH stock has cratered in price, after its e-commerce platform (Wish.com) experienced a user exodus, declining sales, and very high operating losses. Source: Ralf Liebhold / Shutterstock.com As you may know, the company has been
0 Comments
Despite the global pandemic receding, cruise line operator Carnival Corp. (NYSE:CCL) continues to navigate choppy waters. CCL stock is going to need more than just a life raft to recover from the pandemic. Source: Kokoulina / Shutterstock.com Carnival’s stock has been as unpredictable as its sailing schedule lately. Year-to-date, the company’s share price is up
0 Comments
Bionano Genomics (NASDAQ:BNGO) is a life sciences instrumentation company focused on the genome analysis space. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. Source: Dennis Diatel / Shutterstock.com The firm has discovered research about cancer, genetic diseases, and genome assembly, whereas its clinical research is about Facioscapulohumeral Muscular Dystrophy (FSHD) and
0 Comments
As home prices surge, it must make sense to buy OpenDoor Technologies (NASDAQ:OPEN) stock, the high-tech house flipper. Source: Tada Images / Shutterstock.com Right? Wrong. Since the start of 2022, OpenDoor stock is down 35%. Zillow Group (NASDAQ:Z), which got out of the iBuyer market because it couldn’t make money in it, is also down,
0 Comments
There are many U.S.-listed companies with a market capitalization of $3 billion or higher. One of them is Digital World Acquisition (NASDAQ:DWAC). What’s more, year-t0-date (YTD), DWAC stock is currently in the top five best performer amongst this large cohort of $3 billion-plus market-cap stocks. Source: rafapress / Shutterstock Care to guess what the first-best
0 Comments
Sometimes, it’s fun to think about the good old days. Remember when Block (NYSE:SQ) was known as Square, not too long ago? SQ stock holders could simply view the company as an app-based credit-card reader business. Source: Sergei Elagin / Shutterstock.com Then, things got complicated. CEO Jack Dorsey decided to “pull a Zuckerberg” and suddenly change
0 Comments
It’s last call at the Covid-19 vaccine party and shareholders of Novavax (NASDAQ:NVAX) stock should be headed for the coat check. Source: rarrarorro / Shutterstock.com Novavax’s share price is down 41% year-to-date, bringing its six-month decline to 65%. The prospects of the biopharmaceutical company bringing a vaccine against Covid-19 to market in the U.S. grow
0 Comments